Russell Michael W, Childers Noel K, Michalek Suzanne M, Smith Daniel J, Taubman Martin A
Department of Oral Biology, University at Buffalo, Buffalo, NY 14214, USA.
Caries Res. 2004 May-Jun;38(3):230-5. doi: 10.1159/000077759.
Studies performed in numerous laboratories over several decades have demonstrated the feasibility of immunizing experimental rodents or primates with protein antigens derived from Streptococcus mutans or Streptococcus sobrinus against oral colonization by mutans streptococci and the development of dental caries. Protection has been attributed to salivary IgA antibodies which can inhibit sucrose-independent or sucrose-dependent mechanisms of streptococcal accumulation on tooth surfaces according to the choice of vaccine antigen. Strategies of mucosal immunization have been developed to induce high levels of salivary antibodies that can persist for prolonged periods and to establish immune memory. Studies in humans show that salivary antibodies to mutans streptococci can be induced by similar approaches, and that passively applied antibodies can also suppress oral re-colonization by mutans streptococci. Progress towards practical vaccine development requires evaluation of candidate vaccines in clinical trials. Promising strategies of passive immunization also require further clinical evaluation.
几十年来,众多实验室开展的研究表明,用变形链球菌或远缘链球菌的蛋白质抗原免疫实验啮齿动物或灵长类动物,以防止变形链球菌在口腔定植和龋齿发生是可行的。根据疫苗抗原的选择,这种保护作用归因于唾液IgA抗体,它可以抑制链球菌在牙齿表面聚集的不依赖蔗糖或依赖蔗糖的机制。已经开发出黏膜免疫策略,以诱导能长期持续存在的高水平唾液抗体,并建立免疫记忆。对人类的研究表明,类似方法可诱导出针对变形链球菌的唾液抗体,被动应用的抗体也能抑制变形链球菌在口腔中的重新定植。开发实用疫苗的进展需要在临床试验中对候选疫苗进行评估。有前景的被动免疫策略也需要进一步的临床评估。